Stay updated with breaking news from Clipping surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results published in the Journal of Neurosurgery show that clazosentan significantly reduced the combined incidence of vasospasm-related morbidity and all-cause mortality post-aSAH with no unexpected. | April 4, 2022 ....
Results published in the Journal of Neurosurgery show that clazosentan significantly reduced the combined incidence of vasospasm-related morbidity and all-cause mortality post-aSAH with no unexpected safety ....
Investegate announcements from Idorsia Pharmaceuticals Ltd, The Journal of Neurosurgery reports impact of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage ....